|
AU2903999A
(en)
|
1998-03-12 |
1999-09-27 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
CN1635876A
(zh)
|
2000-02-04 |
2005-07-06 |
杜克大学 |
人免疫缺陷病毒疫苗
|
|
WO2001083535A2
(en)
*
|
2000-05-02 |
2001-11-08 |
Simon Fraser University |
Polypeptides for use as a vaccine and/or treatment for hiv infection
|
|
US20030228320A1
(en)
*
|
2000-08-18 |
2003-12-11 |
Ashdown Martin Leonard |
Retroviral immunotherapy
|
|
AUPS065002A0
(en)
|
2002-02-20 |
2002-03-14 |
Immunaid Pty Ltd |
Strategy for retroviral immunotherapy
|
|
AU2001291049A1
(en)
|
2000-09-15 |
2002-03-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Defensin-antigen fusion proteins
|
|
AU2001291050A1
(en)
|
2000-09-15 |
2002-03-26 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Viral chemokine-tumur antigen fusion proteins
|
|
US20060116325A1
(en)
*
|
2001-02-15 |
2006-06-01 |
Oleg Chertov |
Methods and compositions for inhibiting hiv-coreceptor interactions
|
|
AUPS054702A0
(en)
*
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
EP1578766B1
(en)
*
|
2002-12-03 |
2013-02-13 |
University of Massachusetts |
Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
|
|
US20050025779A1
(en)
*
|
2003-06-12 |
2005-02-03 |
Vaxgen, Inc. |
HIV-1 envelope glycoproteins having unusual disulfide structure
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
EP1692516B1
(en)
*
|
2003-10-24 |
2010-12-01 |
Immunaid Pty Ltd |
Method of therapy
|
|
US20080248022A1
(en)
*
|
2004-09-08 |
2008-10-09 |
Immunaid Pty Ltd |
Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
|
|
EP1794327B1
(en)
*
|
2004-09-14 |
2016-11-30 |
Argos Therapeutics, Inc. |
Strain independent amplification of pathogens and vaccines thereto
|
|
JP2009509970A
(ja)
*
|
2005-09-22 |
2009-03-12 |
プロサイ インコーポレイテッド |
酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
|
|
US8221981B2
(en)
*
|
2007-07-30 |
2012-07-17 |
Argos Therapeutics, Inc. |
Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides
|
|
CN102123724B
(zh)
|
2008-06-19 |
2018-05-01 |
变异生技公司 |
治疗流行性感冒的组合物和方法
|
|
DK2435825T3
(en)
|
2009-05-27 |
2015-10-19 |
Biotempus Ltd |
Modes for medical care
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
US9849173B2
(en)
|
2009-07-06 |
2017-12-26 |
Variation Biotechnologies Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
ES2625406T3
(es)
|
2010-03-25 |
2017-07-19 |
Oregon Health & Science University |
Glicoproteínas de CMV y vectores recombinantes
|
|
BR112013000394B8
(pt)
|
2010-07-06 |
2022-01-18 |
Variation Biotechnologies Inc |
Composição imunogênica, uso da mesma e método para preparar a referida composição
|
|
CN103501811B
(zh)
|
2011-01-13 |
2016-03-30 |
变异生物技术公司 |
用于治疗病毒感染的组合物和方法
|
|
SMT201800284T1
(it)
|
2011-06-10 |
2018-07-17 |
Univ Oregon Health & Science |
Glicoproteine cmv e vettori ricombinanti
|
|
CA2789539A1
(en)
|
2011-09-12 |
2013-03-12 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
AU2013208693B2
(en)
|
2012-01-12 |
2017-12-07 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
EP2806894A4
(en)
|
2012-01-27 |
2015-11-04 |
Variation Biotechnologies Inc |
METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
|
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
|
CN104955847A
(zh)
|
2012-12-04 |
2015-09-30 |
马里兰州大学(巴尔的摩) |
HIV-1 Env结合抗体、融合蛋白及其使用方法
|
|
EP2848937A1
(en)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Methods of identifying novel HIV-1 immunogens
|
|
US10058604B2
(en)
|
2013-10-07 |
2018-08-28 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
|
EP3072901A1
(en)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|